United Cannabis Corp's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2019 to a ratio of 89.82, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2019. Average receivable collection period, for the United Cannabis in Sep 30 2019 quarter, has decreased to 4 days, compared to 5 days, in the Jun 30 2019 quarter.

If we take a look into Healthcare sector 56 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. 733.

What is Receivable Turnover Ratio?
What is United Cannabis Corp Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CNAB Receivables Turnover Ratio	(Sep 30 2019) III. Quarter	(Jun 30 2019) II. Quarter	(Mar 31 2019) I. Quarter	(Dec 31 2018) IV. Quarter	(Sep 30 2018) III. Quarter
Y / Y Receivable Change	-23.93 %	168.65 %	-6.32 %	-	191.59 %
Y / Y Revenue Change	121.55 %	112.77 %	1557.07 %	-	1977.05 %
Receivable Turnover Ratio (TTM)	89.82	70.99	77.26	48.88	49.87
CNAB's Total Ranking	# 733	# 733	# 736	# 155	# 733
Accounts Receivable average collection period days	4	5	5	7	7
Seq. Receivable Change	-48.54 %	485.73 %	-82.09 %	40.87 %	81.75 %
Seq. Revenue Change	19.25 %	-10.22 %	47.86 %	39.95 %	14.53 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 16
Healthcare Sector	# 57
Overall Market	# 733

Receivable Turnover Ratio Statistics
High	Average	Low
3.57	0.89	0.08
(Mar 31 2017)		(Mar 31 2018)

CNAB Company Profile • Back to CNAB Efficiency Comparisons • Compare CNAB Receivables Turnover Ratio to its Competitors

Financial Statements
United Cannabis's Accounts Receivable	$ 0 Millions	Visit CNAB's Balance sheet
United Cannabis's Sales TTM	$ 16 Millions	Visit CNAB's Income Statement
Sources of CNAB's Revenues		Visit CNAB's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CNAB's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CNAB's Growth Rates	CNAB's Roa	CNAB's Inventory Turnover Ratio	CNAB's Dividend Comparisons
CNAB's Profitability Ratios	CNAB's Roi	CNAB's Asset Turnover Ratio	CNAB's Dividend Growth
CNAB's Valuation Ratios	CNAB's Roe	CNAB's Financial Strength Ratios	CNAB's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2019, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2019	Receivable at quarter ending Sep 30 2019
Arcus Biosciences Inc	313.20	$ 6.812 Millions	$ 0.022 Millions
Arena Pharmaceuticals Inc	277.89	$ 812.077 Millions	$ 2.922 Millions
Pfenex Inc	269.25	$ 31.772 Millions	$ 0.118 Millions
Diversicare Healthcare Services Inc	249.51	$ 528.017 Millions	$ 2.116 Millions
Siga Technologies Inc	176.41	$ 485.755 Millions	$ 2.754 Millions
Editas Medicine Inc	162.79	$ 14.366 Millions	$ 0.088 Millions
U s Stem Cell Inc	154.41	$ 4.427 Millions	$ 0.029 Millions
Logicmark Inc	130.93	$ 15.747 Millions	$ 0.120 Millions
Optinose Inc	119.70	$ 26.573 Millions	$ 0.222 Millions
Mersana Therapeutics inc	114.39	$ 43.269 Millions	$ 0.378 Millions
Decoy Therapeutics Inc	112.87	$ 1.334 Millions	$ 0.012 Millions
Chemocentryx Inc.	110.55	$ 61.494 Millions	$ 0.556 Millions
Exicure Inc	110.22	$ 0.992 Millions	$ 0.009 Millions
Innovage Holding Corp	107.17	$ 22.719 Millions	$ 0.212 Millions
United Cannabis Corp	89.82	$ 16.082 Millions	$ 0.179 Millions
Agenus Inc	77.86	$ 121.997 Millions	$ 1.567 Millions
Voyager Therapeutics Inc	71.56	$ 73.725 Millions	$ 1.030 Millions
Vystar Corporation	65.18	$ 6.509 Millions	$ 0.100 Millions
Lifevantage Corp	62.82	$ 226.577 Millions	$ 3.607 Millions
Lifemd Inc	61.12	$ 10.709 Millions	$ 0.175 Millions
H cyte Inc	59.08	$ 6.712 Millions	$ 0.114 Millions
Akcea Therapeutics Inc	56.14	$ 221.260 Millions	$ 3.941 Millions
Scorpius Holdings inc	55.93	$ 3.108 Millions	$ 0.056 Millions
Ayala Pharmaceuticals Inc	54.92	$ 20.884 Millions	$ 0.380 Millions
U S Physical Therapy Inc	54.28	$ 477.204 Millions	$ 8.791 Millions
Cti Biopharma Corp	54.25	$ 17.822 Millions	$ 0.329 Millions
Bicycle Therapeutics Plc	53.39	$ 0.614 Millions	$ 0.012 Millions
Mimedx Group Inc	53.27	$ 315.441 Millions	$ 5.922 Millions
Nuo Therapeutics Inc	48.19	$ 0.953 Millions	$ 0.020 Millions
Nanomix Corp	47.08	$ 0.020 Millions	$ 0.000 Millions

Date modified: 2026-09-12T06:21:14+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.